Leading brokers name 3 ASX shares to sell today

Here's why brokers are bearish on these ASX shares…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

On Monday I looked at three ASX shares brokers have given buy ratings to this week.

Unfortunately, not all shares are in favour with them right now. Three that have just been given sell ratings are listed below. Here's why these brokers are bearish on these ASX shares:

Business man marking Sell on board and underlining it

Image Source: Getty Images

Australia and New Zealand Banking GrpLtd (ASX: ANZ)

According to a note out of Citi, its analysts have downgraded this banking giant's shares to a sell rating and reduced the price target on them to $28.00. Citi has been looking at recent updates in the sector and has concerns over ANZ's Markets revenues. And as this has been driving its core profits recently, it suspects that ANZ could fall well short of consensus expectations in FY 2021. The ANZ share price is trading at $28.43 on Tuesday.

Coles Group Ltd (ASX: COL)

A note out of UBS reveals that its analysts have resumed coverage on this supermarket operator's shares with a sell rating and $16.50 price target. UBS believes that Coles is losing market share both in-store and online. And while it is investing heavily in its online business and supply chain, the broker notes that its main rival is too. As such, it suspects the gap may only narrow slightly despite this investment. The Coles share price is fetching $18.31 today.

Ramsay Health Care Limited (ASX: RHC)

Analysts at Morgan Stanley have retained their underweight rating and $57.00 price target on this private hospital operator's shares ahead of its full year results. According to the note, the broker is expecting Ramsay to report a 17% increase in profit in FY 2021. However, it has concerns over the impact that COVID-19 is having and will have on its performance in FY 2022. In light of this uncertainty, it feels the company may struggle to provide guidance for the year ahead. The Ramsay share price is trading at $69.00 on Tuesday.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended COLESGROUP DEF SET. The Motley Fool Australia has recommended Ramsay Health Care Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

An oil refinery worker checks her laptop computer in front of a backdrop of oil refinery infrastructure.
Broker Notes

With oil prices falling, should I still buy Santos shares now?

A leading analyst provides his forecast for Santos' outperforming share price.

Read more »

Two ASX share investors sharing a secret.
Broker Notes

Buy, hold, sell: Flight Centre, Supply Network, Lottery Corporation shares

Experts reveal their ratings on three ASX shares in the consumer discretionary sector.

Read more »

Six smiling health workers pose for a selfie.
Broker Notes

Buy, hold, sell: Charter Hall, Northern Star, Cochlear shares

We review three fresh buy, hold, and sell calls from expert market analysts.

Read more »

Buy, hold, and sell ratings written on signs on a wooden pole.
Broker Notes

Down 53%, is it time to throw in the towel on CSL shares?

A leading analyst delivers his verdict on CSL’s plunging share price.

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Broker Notes

Up 293%! Can Electro Optic Systems (EOS) shares keep rising?

Bell Potter believes this high-flying stock hasn't peaked yet.

Read more »

Five healthcare workers standing together and smiling.
Broker Notes

Up 21% since November, should I buy this dividend paying ASX All Ords healthcare share today?

A leading expert tips one ASX All Ords share to buy and one to sell today.

Read more »

Time to sell written on a clock.
Broker Notes

3 reasons why experts think CSL shares are a sell

Earnings pressure and downgrades weigh heavily on the biotech stock.

Read more »

gold, gold miner, gold discovery, gold nugget, gold price,
Broker Notes

With the gold price up on Monday, are Northern Star shares a good buy now?

A leading analyst provides his outlook for Northern Star’s shares.

Read more »